Btc Capital Management buys $2,960,792 stake in Cardinal Health Inc (CAH)

Cardinal Health Inc (CAH) : Btc Capital Management scooped up 1,040 additional shares in Cardinal Health Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 1, 2016. The investment management firm now holds a total of 34,981 shares of Cardinal Health Inc which is valued at $2,960,792.Cardinal Health Inc makes up approximately 0.62% of Btc Capital Management’s portfolio.

Other Hedge Funds, Including , Everence Capital Management Inc boosted its stake in CAH in the latest quarter, The investment management firm added 3,620 additional shares and now holds a total of 8,170 shares of Cardinal Health Inc which is valued at $691,509. Cardinal Health Inc makes up approx 0.21% of Everence Capital Management Inc’s portfolio.1st Source Bank reduced its stake in CAH by selling 53 shares or 0.12% in the most recent quarter. The Hedge Fund company now holds 44,869 shares of CAH which is valued at $3,751,048. Cardinal Health Inc makes up approx 0.41% of 1st Source Bank’s portfolio. Achievement Holdings sold out all of its stake in CAH during the most recent quarter. The investment firm sold 6,000 shares of CAH which is valued $500,040.Cwm boosted its stake in CAH in the latest quarter, The investment management firm added 205,904 additional shares and now holds a total of 206,114 shares of Cardinal Health Inc which is valued at $17,105,401. Cardinal Health Inc makes up approx 1.20% of Cwm’s portfolio.

Cardinal Health Inc closed down -1.06 points or -1.25% at $83.58 with 17,93,462 shares getting traded on Thursday. Post opening the session at $84.52, the shares hit an intraday low of $83.51 and an intraday high of $84.8 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.

On the company’s financial health, Cardinal Health Inc reported $1.14 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.13. The company had revenue of $31384.00 million for the quarter, compared to analysts expectations of $31167.11 million. The company’s revenue was up 13.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.00 EPS.

Many Wall Street Analysts have commented on Cardinal Health Inc. Cardinal Health Inc was Resumed by BofA/Merrill to “Neutral” on Jun 7, 2016.

Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Cardinal Health Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Cardinal Health Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.